We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
New AI sandbox will help make medicines safer, speed up development, and reduce reliance on animal testing.
As with all medicines, the MHRA will keep the safety and effectiveness of Nipolcalimab under close review.
The annual flu letter describes the national flu immunisation programme and outlines which groups are eligible for flu vaccination.
Government consults on new rights for unpaid carers and parents of seriously ill children, including whether paid leave could improve job opportunities.
First published during the 2024 to 2026 Starmer Labour government
Government invests £20 million to digitise referrals from the high street directly and digitally into NHS hospital eye services.
Policy Lab worked with the Department of Health and Social Care to develop a co-design toolkit enabling parents and carers to shape early years services.
Policy Lab worked with MHCLG's Changing Futures programme to shape services around the lived experience of people facing multiple disadvantage.
Avacopan is used in the treatment of some rare autoimmune diseases affecting small blood vessels.
Infected Blood Compensation Authority's update that was circulated on 4 June 2026
The adjuvanted trivalent influenza vaccine works by stimulating the immune system to produce its own protection against flu.
Government to act on Lord Mann’s report about tackling racism and antisemitism in the NHS.
Resmetirom is used in adults who have experienced inflammation and cell damage, resulting in scarring.
Patients set to benefit from the first sustained expansion of dental school places in nearly 20 years.
Government announces over £20 million to improve prostate cancer research and treatment, including improving access to a major trial for Black men.
While this decline is a cause for optimism, syphilis diagnoses in heterosexual women increased.
NHS modernisation bill will introduce the single patient record, resulting in safer, more co-ordinated care for patients.
The raid on a Northamptonshire estate dismantled what is believed to be a major illicit manufacturing and distribution operation
As with any medicine, the MHRA will keep the safety and effectiveness of rilzabrutinib under close review.
Patients will benefit from more services and treatments from their community pharmacy, as part of a new deal.
Patients taking Crescent Pharma Limited Ramipril 2.5mg capsules are advised to check their packaging for batch number GR155023 and contact their pharmacy if any blister strips inside are labelled as Ramipril 10mg.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).